Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries AbbVie (NY: ABBV ) 166.41 +1.75 (+1.06%) Official Closing Price Updated: 7:00 PM EDT, Apr 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about AbbVie < Previous 1 2 3 4 5 6 7 8 9 ... 53 54 Next > These 3 Small-Cap Stocks Are Up 304% in 2024. Can They Run Higher? Today 14:30 EDT Small-cap stocks have been the market laggards but these standouts showed how to beat even top-tier tech names at their own game. Via InvestorPlace The Bad News Heading Into AbbVie's First-Quarter Earnings Report Today 12:43 EDT AbbVie is working against numerous biosimilar versions of Humira. But one has "stepped up dramatically." Via Investor's Business Daily Soon To Be Acquired Cerevel Therapeutics Reveals High Level Data From Late-Stage Parkinson's Disease Study April 18, 2024 Discover toplines results of Cerevel Therapeutics' Phase 3 TEMPO-3 trial for tavapadon in Parkinson's disease treatment. Statistically significant efficacy and safety findings were revealed. Via Benzinga Is Your Botox Real Or Fake? Counterfeit Boxes Circulate For Widely Used Antiwrinkle Treatment, CDC And FDA Investigate Harmful Reactions April 17, 2024 Be cautious of counterfeit Botox for cosmetic use. FDA warns of adverse reactions in multiple states. Symptoms include vision issues, difficulty breathing, and weakness. Ensure authenticity before... Via Benzinga Exposures Product Safety $1000 Invested In This Stock 5 Years Ago Would Be Worth $2,100 Today April 17, 2024 Via Benzinga AbbVie's Options Frenzy: What You Need to Know April 15, 2024 Via Benzinga Is AbbVie a Millionaire Maker? April 14, 2024 Everything is going according to plan, and more growth is on the way. Via The Motley Fool Smart Money Is Betting Big In ABBV Options April 12, 2024 Via Benzinga AbbVie Unusual Options Activity For April 05 April 05, 2024 Via Benzinga Powell And The Great Indecision April 16, 2024 In today’s presser, Powell basically said what he typically says. Higher for longer but maybe not as risks remain to the economy while inflation is too sticky. Via Talk Markets Topics Economy Exposures Economy Interest Rates Steady Income, Steady Growth: 7 Blue-Chip Dividend Stocks to Buy Now April 16, 2024 With an already tense situation becoming even more troubling, now’s the time to consider blue-chip dividend stocks to buy. Via InvestorPlace Avalo Therapeutics' Newly Acquired Ex-Eli Lilly Drug Could Stand Out In Competitive Hidradenitis Suppurativa Market, Analyst Upgrades April 16, 2024 Unlock the potential of Avalo Therapeutics with AVTX-009, a promising drug for hidradenitis suppurativa. Oppenheimer upgrades to Outperform, foreseeing Phase 2 progress and market distinction. Via Benzinga Neumora Stock Hits 2024 Low As Side Effects In Rabbits Torpedo Schizophrenia Drug April 15, 2024 The company was testing a potential treatment for schizophrenia in rabbits, but found a notable side effect. Via Investor's Business Daily What's Going On AbbVie Stock On Friday? April 12, 2024 AbbVie releases interim analysis on atogepant, an oral migraine prevention drug. Key findings show significant reductions in migraine days and consistent safety profile. Atogepant, known as Qulipta... Via Benzinga Smart Money Is Betting Big In ABBV Options April 04, 2024 Via Benzinga Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for April 2024 April 11, 2024 In a stock picker’s market, here are three biotech stocks analysts believe have a chance to outperform the market in 2024. Via InvestorPlace The $5 BILLION Reason Alpine Immune Sciences (ALPN) Stock Is Up 30% Today April 11, 2024 Vertex hopes Alpine's drug can be tested on other conditions beyond the one entering Phase 3 trial for a kidney disease. Via InvestorPlace Blindness-Focused LENZ Therapeutics' Investigational Eye Drop Ready To Revolutionize Presbyopia Landscape, Analyst Says April 10, 2024 Advances in presbyopia treatment with LENZ Therapeutics' LNZ100. Clinically proven to enhance near-vision for up to 10 hours, it offers a promising alternative to reading glasses. Analysts predict a... Via Benzinga 3 Dividend Growth Stocks With Yields Above 3% That You Can Buy and Hold for the Next Decade April 09, 2024 Income-seeking investors can look forward to steady payout raises from these pharma stocks. Via The Motley Fool 3 No-Brainer Dividend Stocks to Buy in April April 06, 2024 Income investors will find a lot to like about these stocks. Via The Motley Fool Passive Income Perfection: 7 Dividend Stocks to Generate $50,000 Per Year April 04, 2024 These seven dividend stocks provide a base for $50,000 in income per year for dedicated investors with patience. Via InvestorPlace 10 Health Care Stocks Whale Activity In Today's Session April 03, 2024 Via Benzinga FibroGen Unveils Early Data From Prostate Cancer Candidate, Analyst Advocates Further Exploration In The Landscape April 03, 2024 FibroGen reveals Phase 1 results for FG-3246 for metastatic castration-resistant prostate cancer. Promising efficacy metrics and plans for enhanced therapeutic strategies signal potential advancements... Via Benzinga The 3 Best Stocks to Buy in April 2024 April 02, 2024 With market dynamics shifting in the wind, concerned investors may want to target these ideas for best stocks to buy in April. Via InvestorPlace Roivant Sciences Stock Flirts With Breakout On 'Extremely Positive' Eye-Disease Study April 02, 2024 The company hopes to treat noninfectious uveitis and is rivaling AbbVie's Humira. Via Investor's Business Daily Got $3,000? 2 Monster Growth Stocks to Buy Right Now Without Hesitation April 02, 2024 These stocks can deliver powerhouse portfolio growth in the years ahead. Via The Motley Fool Meet The "Magnificent Seven" of Healthcare Stocks April 01, 2024 The tech sector doesn't have a monopoly on magnificent corporations. Via The Motley Fool 3 Reliable Dividend Growth Stocks With Yields Above 3% That You Can Buy Now and Hold for at Least a Decade March 30, 2024 These advantaged businesses have what it takes to keep raising their payouts. Via The Motley Fool 10 Health Care Stocks With Whale Alerts In Today's Session March 28, 2024 Via Benzinga Race To Treat Alzheimer's Disease Is Heating Up Despite Eli Lilly's Setback March 28, 2024 The FDA has delayed making a decision on Eli Lilly's donanemab, pending an advisory committee meeting. Via Investor's Business Daily Exposures Product Safety < Previous 1 2 3 4 5 6 7 8 9 ... 53 54 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.